Table: begin end state 1 19 cytoplasmic 20 39 transmembrane 40 44 non-cytoplasmic 45 70 transmembrane 71 107 cytoplasmic 108 132 transmembrane 133 144 non-cytoplasmic 145 163 transmembrane 164 168 cytoplasmic 169 191 transmembrane 192 202 non-cytoplasmic 203 223 transmembrane 224 255 cytoplasmic 256 279 transmembrane 280 314 non-cytoplasmic 315 341 transmembrane 342 352 cytoplasmic 353 378 transmembrane 379 387 non-cytoplasmic 388 406 transmembrane 407 412 cytoplasmic 413 429 transmembrane 430 464 non-cytoplasmic 465 487 transmembrane 488 500 cytoplasmic
Input: >RR42_RS34870 FitnessBrowser__Cup4G11:RR42_RS34870 MELIDHLALGFSTALSLQNLAYAFLGCVLGTLIGVLPGLGPLATIAMLLPVTYTLPPVAA LIMLAGIYYGAQYGGSTTAILVNLPGESSSVVTTIDGYQMARRGRAGVALATAGLGSFFA GCVATLILAAFATPLSELAFKFGPAEYFSLMCLGLIGAVVLASGSLPKAVAMIVLGLLLG LIGTDVNSGAARFSFDIPELTDGIDFVALAMGMFGFAEIIANLEQKEARETFTDSVTNLW PTREDFRRMIPAVLRGTFLGSALGILPGGGAALASFAAYSLEKKTSKYAHEFGKGAIEGV AGPESANNAAAQTSFIPLLTLGIPPNAVMALMVGAMTIHNIQPGPQVMTSNPALFWGLIA SMWIGNLMLIILNLPMIGVWVKLLTVPYRYLYPAILVFCGIGVYSVNNQTFDVFMAAGFG IIGYLFLKLKCEPAPLLLGFVLGPMMEENFRRSLLLSRGEFTVFVTRPLSLGLLIAAASL VAIVALPSIKAKREEAFQEE
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server